306 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
ePOSTER SESSIONS
298
008
A pilot trial of sodium benzoate, a d-amino acid
oxidase inhibitor added on augmentative and alter-
native communication intervention for non-commu-
nicative children with autism spectrum disorders
Pinchen Yang, Taiwan
Hsiu-Yi Hsu, Chen-Lin Chang Chang
009
Autistic traits and criminality – a study among
prisoners in a high security facility
Ana Machado, Portugal
Diana Rafaela, Joaquim Cerejeira
010
Physical activity and mental health in Spanish
children and adolescents
Ruben Martin Aragon, Spain
Nuria Chinchurreta De Lora, Natalia Rodríguez Criado,
Paloma Muñoz-Calero Franco, Leticia Cobo Calvo,
Andrea Muñoz Domenjó, Raquel Molina Cambra
011
Epidemiological study of mental health in chil-
dren and adolescents population in Saratov region
in 2000–2012
Anastasiya Antonova, Russia
Boris Tsygankov, Yulia Barylnik, Natalia Filippova, Yulia
Abrosimova, Elena Kolesnichenko, Svetlana Pakhomova,
Daria Samoilova, Egor Bachilo, Margarita Deeva, Sergey
Sizov
012
Evaluation of psychological discomfort in
non-consultant students at the faculty of medicine
of the University of Chile
Leonor Villacura Avendaño, Chile
Ilse López, Mateo Zamorano, Fabiola Sánchez, Claudia
Zamorano
013
Non-suicidal self-injury in a high school popula-
tion in Tirana: general trends and sex differences
Besmira Zenelaj, Albania
Valbona Alikaj, Taulant Jupe, Ela Mitro
014
Outcome of depressive and anxiety disorders
among young adults in Finland: results from the
Finnish Health 2011 study
Teija Kasteenpohja, Finland
Mauri Marttunen, Terhi Aalto-Setälä, Anu Castaneda,
Jonna Perälä, Samuli Saarni, Jaana Suvisaari
015
Comorbidity in mentally retarded children
Ambrish Mishra, India
Sanjay Laharia
eP-11
ePoster Session
13:30– 15:00
|
Hall Budapest
|
Terminal 2
TOPIC 9:
Comorbidity of somatic and mental disorders,
psychosomatics
Comorbidity of somatic and mental disorders,
psychosomatics
Chair:
Anna Thomas, Germany
001
Interface between physical health and mental
health care in clinical management
Ting Miller, United Kingdom
Ted Agadagba
002
Myasthenia Gravis: comorbid psychiatric disor-
ders and treatment concerns
Carolina Machado, Portugal
Bárbara Almeida, Cristina Fragoeiro, Lília Monteiro
003
Unusual presentation of serotonin syndrome
after the use of safinamide and citalopram in a
patient with a deep brain stimulator for Parkinson
disease
Gregorio Montero Gonzalez, Spain
Amira Trabsa, Silvia Gasque, Alvaro Jose Palma,
Marc Grifell, Victor Perez-Sole, Liliana Galindo
004
Neuropsychiatric manifestations in Cushing's
Syndrome – review about a case report
Vânia Gonçalves, Portugal
André Ribeirinho Marques, Liliana Pereira Ferreira,
Alda Rosa
005
Schizophrenia and coronary artery disease:
a case report
Aroua Rebai, Tunisia
006
Prevalence of depression and anxiety among
coronary patients
Abderraouf Ferchichi, Tunisia
Maroua Daoud, Aida Bejjar, Myriam Mlika, Omar Abid,
Emna Allouch, Hedi Baccar, Olfa Moula, Rym Ghachem
007
Neuropsychiatric alterations in inflammatory
bowel disease: report of a case
Rocio Molina Prado, Spain
Francisca Cartas Moreno, Sabina Zubimendi Perez
008
Impact of affective disorders as comorbidity in
inflammatory bowel disease on patient prognosis
and treatment
Adriana Mihai, Romania
Vlad Soare